[Use of low molecular-weight heparin in hemodialysis patients].
Low-molecular-weight (LMW) heparin has been compared to standard unfractionated (UF) heparin in a total of 49 patients on hemodialysis and hemofiltration in order to determine the necessary therapeutic dose and its effect on the coagulation system. A LMW heparin dose corresponding to 50% of the normal UF heparin dose was found to produce similar plasma heparin levels (anti-FXa-U/ml) in particular on minimal heparinization. At higher doses, UF heparin produced a more marked increase in plasma-heparin than did LMW heparin. Highly significant differences were found between UF and LMW heparin in their effects on PTT and thrombin time. Partial thromboplastin time (PTT) increased under UF heparin by an average of 120 s whereas LMW heparin only produced an increase of 5-7 s. Thrombin time was increased by 250-280 s under UF heparin and by 5-8 s under LMW heparin. With this LMW heparin dose of 50% of the UF heparin dose, no thrombosis of the extracorporal system occurred and no macroscopic detectable thrombotic material was found in the dialyzers or filters. No significant differences were observed between the effects of UF and LMW heparin on Factor VIII activity and fibrin monomers, so that a difference in coagulation activation between the two heparins can be excluded. Furthermore, there were no changes in thromboplastin time according to Quick, fibrinogen, antithrombin III, plasminogen, and a2-antiplasmin.(ABSTRACT TRUNCATED AT 250 WORDS)
D001769:Blood; D001779:Blood Coagulation Factors / Q000378:metabolism; D001780:Blood Coagulation Tests; D004305:Dose-Response Relationship, Drug; D006493:Heparin / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000201:enzymology / Q000628:therapy*; D008071:Lipoprotein Lipase / Q000097:blood; D008970:Molecular Weight; D006435:Renal Dialysis; D014462:Ultrafiltration
D001779:Blood Coagulation Factors; D006493:Heparin; D008071:Lipoprotein Lipase
Anwendung von niedermolekularem Heparin bei Hämodialysepatienten.